Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
published in: The Lancet
date of publication: 2010-08-28
language: English
main subject: chemotherapy, phase III clinical trial, trastuzumab
Cites articles 28
- 2010-03-17
Date
Title
Article - wd:Q27851578